Health Trials

Cancer Treatment-induced Thrombocytopenia (CTIT)

1

Review clinical trials related to Cancer Treatment-induced Thrombocytopenia (CTIT). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia

Evaluation of the Efficacy and Safety of Romiplostim N01 for the Treatment of Cancer Treatment-Induced Thrombocytopenia (CTIT) in Patients with Leukemia

Participants needed: 97
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Anhui Provincial HospitalUpdated: Jul 10, 2026Locations: 1
Eligibility criteria

Age between 18 and 75 years, inclusive, regardless of sex; [+6]

Pregnant or breastfeeding women; [+13]

Read more